New Phase Research Development — Knoxville, Tennessee

New Phase Research Development is a clinical research site located in Knoxville, Tennessee, United States 37909.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

New Phase Research Development has participated in 38 clinical trials with 3 currently active.

Therapeutic areas: Covid19, Chronic Obstructive Pulmonary Disease, Irritable Bowel Syndrome With Diarrhea.

Sponsors: Appili Therapeutics Inc., Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA, Allergan.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Knoxville

Browse all research sites in Tennessee · View every site in Knoxville

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Phase Research Development?

New Phase Research Development has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Phase Research Development conducted?

New Phase Research Development has 38 clinical trials on record, with 3 currently active. Their work covers Covid19, Chronic Obstructive Pulmonary Disease, Irritable Bowel Syndrome With Diarrhea.

Is New Phase Research Development accredited by Crixeo Clinical Trials?

New Phase Research Development has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Phase Research Development?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.